Private company

Cessatech A/S

Cessatech A/S is a Danish Biotechnology company based in Copenhagen.¹

Last updated Oct 21, 2026.

Overview

HeadquartersCopenhagen, Denmark¹
Websitecessatech.com
Legal formaktieselskab¹
LEI549300WO5SKVXWPOXR16²
StatusActive²
LEI statusIssued and current²
Registered addressStrandvejen 60, 2900 Hellerup, Denmark²
Registered withDanish Business Authority, 41293055²

See how the biggest companies compare on our leaderboards

Timeline

Apr 6, 2020Founded Cessatech A/S is founded²

Calendar

Drug trials and FDA: recently

May 9, 2025Phase 2/3 trial completed Phase 2/3 trial of CT001 in Pain: primary completion May 9, 2025, results posted Feb 2, 2026 (ClinicalTrials.gov NCT06364072).³

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). Trials from ClinicalTrials.gov, as the sponsor registered them (expected dates are the sponsor's own and often move); approvals and advisory committee meetings from the FDA. The FDA does not publish its decision (PDUFA) dates. The full markets calendar

Sources

The numbers on this page point here. Each one links to the record it came from.

1
WikidataCessatech A/S on Wikidata
2
GLEIFCessatech A/S LEI record (549300WO5SKVXWPOXR16)
3
ClinicalTrials.govClinicalTrials.gov NCT06364072: Safety, Tolerability, Analgesic Effect, and Feasibility of Intranasal CT001 in Pediatric Patients

Overview

Timeline

Calendar

Drug trials and FDA: recently

Links

Sources